Mimetic Peptide for Biological Product Stability Assessment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing the stability of biological products in prefilled syringes are lengthy, expensive, and specific to each protein, making it challenging to predict chemical degradation and contaminating compound interactions, which are essential for ensuring product quality and safety.
Innovation Solution
A method using a custom-designed mimetic peptide is developed to mimic and assess chemical degradation of biological products when in contact with container components, involving preparing an aqueous solution, adding container parts for contact, and analyzing using liquid chromatography to determine degradation percentage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If long-term accelerated stability studies are conducted with each biological product to assess degradation risk, then product stability assessment accuracy is improved, but study duration and cost increase significantly
Solution Approach 1:
The patent uses a mimetic peptide that copies the essential chemical features (reactive side chains) of biological products without requiring the full protein structure. This simplified model allows degradation risk assessment to be performed on the peptide instead of the complete biological product, dramatically reducing study time while maintaining assessment accuracy for contact-induced degradation mechanisms
Solution Approach 2:
The mimetic peptide serves as a disposable, inexpensive surrogate that can be rapidly tested against container components. Instead of investing months in studying each expensive biological product, manufacturers can quickly screen container materials using the cheap peptide model, identifying suitable containers before committing to long-term stability studies with the actual biological product
2Loss of information
If comprehensive extractables and leachables studies are conducted to identify all potential contaminating compounds, then contaminant identification completeness is improved, but analytical complexity and expertise requirements increase
Solution Approach 1:
The patent extracts only the essential reactive components (amino acid side chains) that are relevant to degradation mechanisms, eliminating the need to analyze the entire biological product or identify every possible contaminant. The mimetic peptide contains only the critical functional groups that interact with container leachables, allowing focused assessment of degradation risk without comprehensive contaminant profiling
Solution Approach 2:
The mimetic peptide concentrates the essential degradation-prone features (specific amino acid side chains) into a localized, simplified structure. This allows the assessment to focus on the specific chemical interactions that matter for stability, rather than requiring comprehensive analysis of all potential contaminants and their effects on the entire biological product
3Measurement precision
If each biological product undergoes individual stability assessment to account for unique protein characteristics, then assessment specificity is improved, but manufacturing scalability deteriorates
Solution Approach 1:
The mimetic peptide serves as a universal model that can be applied across multiple biological products. Since it contains the essential reactive amino acid side chains common to many proteins, a single peptide can screen container compatibility for various biological products, eliminating the need for separate extensive studies for each product while maintaining relevance to actual degradation mechanisms
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the prediction of susceptibility to degradation, facilitates the selection of suitable container materials, and accelerates stability studies, reducing the risk of chemical degradation and ensuring product integrity.
Implementation Method 1
assess the stability of biological product in prefilled syringes... determine the chemical degradation risk of a biological product, the degradation occurring mainly by contact, in particular long term contact, with part of a container
Implementation Method 2
analyzing by liquid chromatography the solution obtained at step ii)
Data Source
AI summary
Provided herein is a method to mimic and assess the chemical degradation risk of a biological product, in prefilled syringes (PFS), using a custom-designed mimetic peptide. Such method is also able to predict the susceptibility to degradation of biological product in solution in a container for medical usage.